Benign Prostatic Hyperplasia Real-World Data
By age 60, half of all men develop benign prostatic hyperplasia (BPH).
Qdata® can help provide a deeper understanding of BPH, accelerating breakthroughs in treatment and patient care.
Qdata® Benign Prostatic Hyperplasia is an exclusive dataset reflective of de-identified U.S. patients with benign prostatic hyperplasia (BPH), providing critical insights into disease progression, disease management, and comorbidities for patients with BPH.
Key Data Elements
Gleason Score
PSA Level
IPSS
By the Numbers
About Qdata® Benign Prostatic Hyperplasia
Benign prostatic hyperplasia (BPH) is a condition in which the prostate is enlarged, which is common as men age. Prostate enlargement can cause bladder, urinary tract or kidney problems. Real-world EHR data can help identify unique patient characteristics and gain a clearer picture of their clinical journey.
As the real-world data (RWD) curation and analytics partner of the American Urological Association (AUA) Quality (AQUA)® Registry, Verana Health has exclusive access to valuable demographic and clinical information on patients with BPH. Qdata BPH empowers researchers to stratify patient populations, assess disease severity, and uncover key comorbidities, such as prostate cancer, enabling more precise and personalized approaches to care.
Qdata BPH by Verana Health is a research-ready, fit-for-purpose real-world data module that provides a more granular understanding of disease progression and patient outcomes for patients with BPH. Key patient outcomes, including PSA levels, International Prostate Symptom Score (IPSS)*, and Gleason scores for those with both BPH and prostate cancer, are meticulously extracted from unstructured clinical notes and semi-structured EHR fields.
Evidence in Action
Exclusive Coverage of the BPH Population
Only available here from the AQUA Registry.
Detailed Understanding of Patient Characteristics
To characterize disease severity and understand who also has prostate cancer.
Granular View of Disease Progression and Patient Outcomes
Key variables such as Gleason score, PSA level, and IPSS.
Custom Data Curation
Need data tailored to your exact study design requirements?
Our purpose-built, fit-for-purpose datasets are designed to support rigorous research and confident decision-making. These datasets can be tailored
around custom inclusion and exclusion criteria, in addition to including all standard abstracted data elements.
Ready to Explore the Benign Prostatic Hyperplasia Dataset?
Connect with our team to discuss your research objectives and receive a tailored data overview.